Journal ArticleBrain Behav Immun · December 10, 2025
Traumatic brain injury (TBI) often leads to neuropathic pain and a range of comorbidities, including post-traumatic stress disorder (PTSD), cognitive decline and depression. Neuroprotectin D1 (NPD1), a lipid mediator derived from the omega-3 fatty acid doc ...
Full textLink to itemCite
Journal ArticleAnesthesiology · August 1, 2025
BACKGROUND: General anesthesia, such as isoflurane, induces analgesia (loss of pain) and loss of consciousness through mechanisms that are not fully understood. A distinct population of γ-aminobutyric acid-mediated neurons has been recently identified in t ...
Full textLink to itemCite
Journal ArticleNeuron · September 6, 2023
Featured Publication
Programmed death protein 1 (PD-1) and its ligand PD-L1 constitute an immune checkpoint pathway. We report that neuronal PD-1 signaling regulates learning/memory in health and disease. Mice lacking PD-1 (encoded by Pdcd1) exhibit enhanced long-term potentia ...
Full textLink to itemCite
Journal ArticlePharmacol Ther · August 2023
Featured Publication
It is generally believed that immune activation can elicit pain through production of inflammatory mediators that can activate nociceptive sensory neurons. Emerging evidence suggests that immune activation may also contribute to the resolution of pain by p ...
Full textLink to itemCite
Chapter · January 1, 2023
Featured Publication
Immunotherapy was initially developed as a method to treat cancer through the use of the host’s immune system. Now, immunotherapy is used as a treatment for a wide variety of diseases. The connection between the nervous system and the immune system in chro ...
Full textCite
Journal ArticleNature communications · November 2022
Featured Publication
Epileptic seizures are widely regarded to occur as a result of the excitation-inhibition imbalance from a neuro-centric view. Although astrocyte-neuron interactions are increasingly recognized in seizure, elementary questions about the causal role of astro ...
Full textCite
Journal ArticleNeurosci Bull · August 2021
Featured Publication
Programmed cell death protein 1 (PD-1) is an immune checkpoint modulator and a major target of immunotherapy as anti-PD-1 monoclonal antibodies have demonstrated remarkable efficacy in cancer treatment. Accumulating evidence suggests an important role of P ...
Full textLink to itemCite
Journal ArticleBrain · March 3, 2021
Opioids such as morphine are mainstay treatments for clinical pain conditions. Itch is a common side effect of opioids, particularly as a result of epidural or intrathecal administration. Recent progress has advanced our understanding of itch circuits in t ...
Full textLink to itemCite
Journal ArticleNature · March 2021
The innate immune regulator STING is a critical sensor of self- and pathogen-derived DNA. DNA sensing by STING leads to the induction of type-I interferons (IFN-I) and other cytokines, which promote immune-cell-mediated eradication of pathogens and neoplas ...
Full textLink to itemCite
Journal ArticleJ Neurosci · December 2, 2020
Oxaliplatin, a platinum-based chemotherapeutic drug, which is used as first-line treatment for some types of colorectal carcinoma, causes peripheral neuropathic pain in patients. In addition, an acute peripheral pain syndrome develop in almost 90% of patie ...
Full textLink to itemCite
Journal ArticleiScience · October 23, 2020
The immune checkpoint inhibitor programmed cell death protein 1 (PD-1) plays a critical role in immune regulation. Recent studies have demonstrated functional PD-1 expression in peripheral sensory neurons, which contributes to neuronal excitability, pain, ...
Full textLink to itemCite
Journal ArticleBiological psychiatry · May 2020
BackgroundPrevious studies indicated the involvement of cholinergic neurons in seizure; however, the specific role of the medial septum (MS)-hippocampus cholinergic circuit in temporal lobe epilepsy (TLE) has not yet been completely elucidated.
Full textCite
Journal ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · April 2020
Featured Publication
Status epilepticus (SE), a life-threatening neurologic emergency, is often poorly controlled by the current pharmacological therapeutics, which are limited to a narrow time window. Here, we investigated the proinflammatory cytokine high mobility group box- ...
Full textCite
Journal ArticleNature communications · February 2020
The precise circuit of the substantia nigra pars reticulata (SNr) involved in temporal lobe epilepsy (TLE) is still unclear. Here we found that optogenetic or chemogenetic activation of SNr parvalbumin+ (PV) GABAergic neurons amplifies seizure a ...
Full textCite
Journal ArticleNeurobiology of disease · September 2018
Temporal lobe epilepsy (TLE) is the most common type of epilepsy and is often medically refractory. Previous studies suggest that selective pharmaco-genetic inhibition of pyramidal neurons has therapeutic value for the treatment of epilepsy, however there ...
Full textCite
Journal ArticleBrain, behavior, and immunity · August 2017
Featured Publication
Brain inflammation is a major factor in epilepsy, and the high mobility group box-1 (HMGB1) protein is known to contribute significantly to the generation of seizures. Here, we investigated the therapeutic potential of an anti-HMGB1 monoclonal antibody (mA ...
Full textCite
Journal ArticleInvestigative ophthalmology & visual science · February 2017
Featured Publication
PurposeNondegradable fluorophores that accumulate as deleterious lipofuscin of RPE are involved in pathological mechanisms leading to the degeneration of RPE in AMD. A2E, a major component of RPE lipofuscin, could cause damage to RPE cells. Nevert ...
Full textCite
Journal ArticleInvestigative ophthalmology & visual science · November 2014
Featured Publication
PurposeRetinal-derived fluorophores that accumulate as RPE lipofuscin are implicated in pathological mechanisms of AMD. One component of RPE lipofuscin has been characterized as pdA2E, a pyridinium adduct derived from all-trans-retinal and excess ...
Full textCite
Journal ArticleThe Biochemical journal · June 2014
Toxic lipofuscin in the RPE (retinal pigment epithelium) is implicated in blindness in AMD (age-related macular degeneration) or recessive Stargardt's disease patients. In the present study, we identified a novel fluorescent lipofuscin component in human a ...
Full textCite